Medical group Tamarind Health had announced on Dec 23, 2024 an offer to purchase shares in TalkMed Group at 45.6 cents per share, valuing the latter at over $606 million.
The Competition and Consumer Commission of Singapore (CCCS) is inviting public feedback on the proposed acquisition of SGX-listed TalkMed Group by Tamarind Health.
CCCS on Jan 13 accepted a joint application from the parties for a decision on whether the proposed transaction would be anti-competitive.
